We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

132 hedge funds and large institutions have $575M invested in Cytokinetics in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more call options, than puts

Call options by funds: $9.37M | Put options by funds: $6.62M

36% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 39

24% more capital invested

Capital invested by funds: $465M → $575M (+$111M)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 136 → 132 (-4)

4.93% less ownership

Funds ownership: 78.84% → 73.92% (-4.9%)

Holders
132
Holders Change
-4
Holders Change %
-2.94%
% of All Funds
3.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
53
Reduced
39
Closed
20
Calls
$9.37M
Puts
$6.62M
Net Calls
+$2.75M
Net Calls Change
-$134K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$15.7M
2
PA
Pinnacle Associates
New York
+$13.8M
3
BlackRock
BlackRock
New York
+$8.16M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.81M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.69M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$10.2M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$5.02M
3
BIM
Bogle Investment Management
Massachusetts
-$4.96M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.3M
5
LCM
Laurion Capital Management
New York
-$3.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$99.3M +$8.16M +597,295 +10%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$65.1M -$1.87M -136,800 -3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$49.1M +$3.69M +270,375 +9%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$40.3M +$1.28M +93,675 +3%
LPU
5
Lansdowne Partners (UK)
United Kingdom
$38.4M – – –
Wellington Management Group
6
Wellington Management Group
Massachusetts
$33.7M -$4.3M -314,989 -12%
State Street
7
State Street
Massachusetts
$26.6M +$2.2M +161,180 +10%
Citadel Advisors
8
Citadel Advisors
Florida
$18.1M +$15.7M +1,150,934 +1,158%
BI
9
BVF Inc
California
$18M -$10.2M -749,300 -38%
PA
10
Pinnacle Associates
New York
$14.6M +$13.8M +1,008,805 New
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
$12.2M +$2.87M +210,195 +33%
Invesco
12
Invesco
Georgia
$11.6M -$523K -38,297 -5%
Citigroup
13
Citigroup
New York
$11.4M -$161K -11,764 -1%
WA
14
Wasatch Advisors
Utah
$10.2M -$909K -66,518 -9%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$8.01M +$348K +25,510 +5%
Northern Trust
16
Northern Trust
Illinois
$6.84M +$62.1K +4,546 +1%
Principal Financial Group
17
Principal Financial Group
Iowa
$6.61M +$392K +28,708 +7%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$6.17M +$5.81M +425,258 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$6.12M -$363K -26,541 -6%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$5.79M -$5.02M -367,186 -48%
Ameriprise
21
Ameriprise
Minnesota
$5.2M +$1.61M +117,882 +49%
Goldman Sachs
22
Goldman Sachs
New York
$5M +$800K +58,548 +20%
Charles Schwab
23
Charles Schwab
California
$4.4M +$316K +23,142 +8%
TCIM
24
TIAA CREF Investment Management
New York
$3.73M -$26.4K -1,929 -0.7%
Morgan Stanley
25
Morgan Stanley
New York
$3.31M -$889K -65,058 -22%
1
2 3 4 5

CYTK Hedge Fund Activity: Q3 2017 in Review

132 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2017, worth a combined $575M — up 24% from $465M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of CYTK and 19 opened new positions — a net loss of 1 holder — while 39 trimmed existing stakes and 53 added.

The largest buyer was Citadel Advisors, adding an estimated $15.7M. The largest seller was BVF Inc, cutting an estimated $10.2M.

  • 132 institutional investors held Cytokinetics (CYTK) as of Q3 2017, down from 136 in Q2 2017.
  • Funds reported $575M of Cytokinetics stock for Q3 2017, up 24% quarter-over-quarter.
  • 19 funds opened new Cytokinetics positions in Q3 2017 and 20 closed out, a net change of -1 holder.
  • The largest Cytokinetics buyer in Q3 2017 was Citadel Advisors, an estimated $15.7M added.
  • The largest Cytokinetics seller in Q3 2017 was BVF Inc, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2017.